• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ASCENSIA DIABETES CARE US INC. CONTOUR NEXT; BLOOD GLUCOSE TEST STRIPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ASCENSIA DIABETES CARE US INC. CONTOUR NEXT; BLOOD GLUCOSE TEST STRIPS Back to Search Results
Model Number 7312
Medical Device Problem Code High Readings (2459)
Health Effect - Clinical Codes Hypoglycemia (1912); Shaking/Tremors (2515)
Date of Event 07/17/2022
Type of Reportable Event Serious Injury
Event or Problem Description
The customer reported that she obtained a blood glucose reading of 159 mg/dl at 5:38 a.M.With the contour next link meter.Based on the meter readings, the customer received humalog from an insulin pump.The customer then experienced symptoms of hypoglycemia which she described as brain not functioning properly and being shaky, hungry and sleepy.The customer went to the hospital where she received juice and food to rehydrate her.The customer recovered well after the treatment.The customer was advised to return the device for evaluation.Replacement meter kit and test strips were sent to the customer.
 
Additional Manufacturer Narrative
The patient/family (a1) was the initial reporter (e1), so personal information was not entered.No information was captured in section a4 as the customer's weight was not provided.
 
Additional Manufacturer Narrative
The customer did not return the suspected device for evaluation.Therefore, an in-house testing was performed with the in-house contour next link meter and in-house contour next test strips from lot # 1mpef02a using blood sample, which gave a satisfactory performance.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CONTOUR NEXT
Common Device Name
BLOOD GLUCOSE TEST STRIPS
Manufacturer (Section D)
ASCENSIA DIABETES CARE US INC.
100 summit lake drive
valhalla NY 10595
Manufacturer (Section G)
PHC CORPORATION (REGISTRATION NUMBER: 1000134386)
2131-1 minamigata
toon ehime, 791-0 395
JA   791-0395
Manufacturer Contact
shweta gulati
100 summit lake drive
valhalla, NY 10595
9142361830
MDR Report Key15894553
Report Number1810909-2022-00185
Device Sequence Number14766911
Product Code NBW
UDI-Device Identifier10301937312219
UDI-Public10301937312219
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
K110894
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Consumer
Initial Reporter Occupation Other
Remedial Action Replace
Type of Report Initial,Followup
Report Date (Section B) 11/14/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Lay User/Patient
Device Expiration Date12/31/2023
Device Model Number7312
Device Catalogue Number7312
Device Lot Number1MPEF02A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 11/14/2022
Supplement Date Received by Manufacturer06/28/2023
Initial Report FDA Received Date12/01/2022
Supplement Report FDA Received Date07/14/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured12/01/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Unknown
Patient Sequence Number1
Patient Age52 YR
Patient SexFemale
-
-